Quantitation of mitochondrial DNA in human lymphoblasts by a competitive polymerase chain reaction method: application to the study of inhibitors of mitochondrial DNA content

H Zhang, DA Cooney, A Sreenath, Q Zhan, R Agbaria, EE Stowe, AJ Fornace and DG Johns

Laboratory of Medicinal Chemistry, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

With increasing awareness of the mitochondrial toxicity associated with certain 2',3'-dideoxynucleosides used in anti-human immunodeficiency virus therapy, procedures for quantitative analyses of drug effects on mitochondrial DNA (mtDNA) have assumed enhanced importance. For this reason we have developed a method to measure the copy numbers of mtDNA in cultured MOLT-4 cells. First a hybrid competitive DNA template was synthesized by conventional polymerase chain reaction (PCR), using two custom-synthesized 40-mer composite primers incorporating mitochondrial displacement loop sequences linked by a non-mitochondrial cDNA template (a 76-base pair sequence from the tat/rev region of human immunodeficiency virus cDNA). For the competitive assay, increasing known copy numbers of the hybrid competitive template were added as an internal control to samples containing total cellular DNA. With this approach, two competitive PCR products were generated, 1) a mitochondrial displacement loop-derived fragment (182 base pairs) and 2) a competitive DNA template-derived fragment (156 base pairs). Absolute quantitation was achieved by radiometric comparison of the relative amounts of the two products. To test the versatility of this method, varying amounts of competitive template (6.6 x 10(4) to 6.6 x 10(9) copies) were used with a fixed quantity of total cellular DNA taken from cells cultured for 9 days in the presence or absence of selected pyrimidine and purine dideoxynucleosides. The results showed that the copy number of cellular mtDNA is 823 +/- 71 copies/cell in MOLT-4 cells. Little selective depletion of mtDNA, compared with total cellular DNA, was seen with the purine dideoxynucleosides examined; however, when the cells were exposed to the pyrimidine dideoxynucleoside 2',3'-dideoxycytidine (50 nM) for 9 days, mtDNA content was specifically depleted, although total cellular DNA decreased by only 10%. Thus, in addition to the presently used methods of assessing mitochondrial impairment, i.e., Southern blot analysis and electron microscopy, the competitive PCR method provides a third and convenient assay, with particular applicability to determination of mtDNA in very small numbers of cells.

Volume 46, Issue 6, pp. 1063-1069, 12/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				A. Pyle, R. W Taylor, S. E Durham, M. Deschauer, A. M Schaefer, D. C Samuels, and P. F Chinnery Depletion of mitochondrial DNA in leucocytes harbouring the 3243A->G mtDNA mutation J. Med. Genet., January 1, 2007; 44(1): 69 - 74. [Abstract] [Full Text] [PDF]

				G. Hudson and P. F. Chinnery Mitochondrial DNA polymerase-{gamma} and human disease Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R244 - R252. [Abstract] [Full Text] [PDF]

				J. C St John, R. E I Lloyd, E. J Bowles, E. C Thomas, and S. El Shourbagy The consequences of nuclear transfer for mammalian foetal development and offspring survival. A mitochondrial DNA perspective Reproduction, June 1, 2004; 127(6): 631 - 641. [Abstract] [Full Text] [PDF]

				F. J. Miller, F. L. Rosenfeldt, C. Zhang, A. W. Linnane, and P. Nagley Precise determination of mitochondrial DNA copy number in human skeletal and cardiac muscle by a PCR-based assay: lack of change of copy number with age Nucleic Acids Res., June 1, 2003; 31(11): e61 - e61. [Abstract] [Full Text] [PDF]

				, J. M. v. , R. , , , G. , H. , , J. , and A. Simultaneous A8344G heteroplasmy and mitochondrial DNA copy number quantification in Myoclonus Epilepsy and Ragged-Red Fibers (MERRF) syndrome by a multiplex Molecular Beacon based real-time fluorescence Nucleic Acids Res., February 1, 2001; 29(3): e13 - e13. [Abstract] [Full Text] [PDF]

				H. K. Bhat, W. R. Hiatt, C. L. Hoppel, and E. P. Brass Skeletal Muscle Mitochondrial DNA Injury in Patients With Unilateral Peripheral Arterial Disease Circulation, February 16, 1999; 99(6): 807 - 812. [Abstract] [Full Text] [PDF]

				P. Hentosh and M. Tibudan 2-Chloro-2'-deoxyadenosine, an Antileukemic Drug, Has an Early Effect on Cellular Mitochondrial Function Mol. Pharmacol., April 1, 1997; 51(4): 613 - 619. [Abstract] [Full Text]